Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Cystic Fibrosis
Cystic Fibrosis News
Ivacaftor Cost-effective Example of Precision Medicine for Cystic FibrosisReal-world data from clinical trials, clinical care and administrative claims suggest that ivacaftor is a "sterling example" of precision medicine for a subpopulation of people with cystic fibrosis, based on their genetic makeup, researchers say.
Reuters Health Information, May 21, 2018
AlertFDA Clears Tezacaftor/Ivacaftor Combo for Cystic FibrosisSymdeko is for people aged 12 years and older who have two copies of the F508del mutation in the CFTR gene or who have at least one mutation that is responsive to tezacaftor/ivacaftor.
